钝性脑血管损伤的评估与管理:东部创伤外科协会实践管理指南
本指南由东部创伤外科协会实践管理指南委员会采用GRADE方法制定,系统评价并Meta分析了98篇文献中的23篇,围绕BCVI筛查方案、颈椎损伤筛查标准、抗血栓治疗(ATT)及血管内支架4个问题给出推荐。结果显示:使用筛查方案较无筛查方案BCVI检出率升高(OR 4.74,95%CI 1.76-12.78,p=0.002);高风险较低风险颈椎损伤患者BCVI检出率升高(OR 12.7,95%CI 6.24-25.62,p=0.003);使用ATT较不用ATT卒中风险降低(OR 0.20,95%CI 0.06-0.65,p<0.0001)、死亡风险降低(OR 0.17,95%CI 0.08-0.34,p<0.0001);Grade II或III级损伤患者支架辅助ATT与单用ATT相比卒中风险无显著差异(OR 1.63,95%CI 0.2-12.14,p=0.63)。指南推荐对钝性多发伤患者采用筛查方案检测BCVI,对高风险颈椎损伤患者推荐CT血管造影筛查,对低风险颈椎损伤患者条件性推荐CT血管造影,推荐BCVI确诊患者使用ATT,不推荐Grade II或III级BCVI患者常规使用血管内支架辅助ATT。
要点
- 推荐对钝性多发伤患者采用筛查方案检测BCVI(EAST指南推荐)。
- 推荐对高风险颈椎损伤患者行CT血管造影筛查BCVI(EAST指南推荐)。
- 对低风险颈椎损伤患者,条件性推荐行CT血管造影检测BCVI(EAST指南条件性推荐)。
- 推荐对确诊BCVI的患者使用抗血栓治疗(EAST指南推荐)。
- 不推荐Grade II或III级BCVI患者常规使用血管内支架辅助抗血栓治疗(EAST指南推荐)。
适用人群与场景
- 钝性多发伤患者,采用筛查方案检测BCVI。
- 高风险颈椎损伤患者,推荐行CT血管造影筛查BCVI。
- 低风险颈椎损伤患者,条件性推荐行CT血管造影筛查BCVI。
- 确诊BCVI的患者,推荐使用抗血栓治疗。
- Grade II或III级BCVI患者,不推荐常规使用血管内支架辅助抗血栓治疗。
处置流程与药物剂量
- 推荐对钝性多发伤患者采用筛查方案检测BCVI(EAST指南推荐)。
- 推荐对高风险颈椎损伤患者行CT血管造影筛查BCVI(EAST指南推荐)。
- 对低风险颈椎损伤患者,条件性推荐行CT血管造影检测BCVI(EAST指南条件性推荐)。
- 推荐对确诊BCVI的患者使用抗血栓治疗(EAST指南推荐)。
- 不推荐对Grade II或III级BCVI患者常规使用血管内支架辅助抗血栓治疗(EAST指南推荐)。
研究设计与关键结果
- 采用GRADE方法系统评价并Meta分析,共鉴定98篇文章,选取23篇构建指南。
- 使用筛查方案较无筛查方案BCVI检出率升高(OR 4.74,95%CI 1.76-12.78,p=0.002)。
- 高风险较小风险颈椎损伤患者BCVI检出率升高(OR 12.7,95%CI 6.24-25.62,p=0.003)。
- 使用ATT较不用ATT卒中风险降低(OR 0.20,95%CI 0.06-0.65,p<0.0001)。
- 使用ATT较不用ATT死亡风险降低(OR 0.17,95%CI 0.08-0.34,p<0.0001)。
- Grade II或III级损伤患者支架辅助ATT与单用ATT相比卒中风险无显著差异(OR 1.63,95%CI 0.2-12.14,p=0.63)。
证据类型、等级与局限
- 证据类型:指南(东部创伤外科协会实践管理指南),证据等级:Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对钝性多发伤患者,应采用筛查方案检测BCVI,以提高检出率(EAST指南推荐)。
- 对高风险颈椎损伤患者,应行CT血管造影筛查BCVI(EAST指南推荐)。
- 对低风险颈椎损伤患者,条件性推荐行CT血管造影检测BCVI(EAST指南条件性推荐)。
- 对确诊BCVI的患者,应使用抗血栓治疗以降低卒中和死亡风险(EAST指南推荐)。
- 对Grade II或III级BCVI患者,不推荐常规使用血管内支架辅助抗血栓治疗(EAST指南推荐)。
指南或共识出处
- 钝性脑血管损伤的评估与管理:东部创伤外科协会实践管理指南(Evaluation and management of blunt cerebrovascular injury: A practice management guideline from the Eastern Association for the Surgery of Trauma),东部创伤外科协会,发表于Journal of Trauma and Acute Care Surgery。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Blunt cerebrovascular injuries (BCVIs) are associated with significant morbidity and mortality. This guideline evaluates several aspects of BCVI diagnosis and management including the role of screening protocols, criteria for screening cervical spine injuries, and the use of antithrombotic therapy (ATT) and endovascular stents.
METHODS: Using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, a taskforce of the Practice Management Guidelines Committee of the Eastern Association for the Surgery of Trauma performed a systematic review and meta-analysis of currently available evidence. Four population, intervention, comparison, and outcome questions were developed to address diagnostic and therapeutic issues relevant to BCVI.
RESULTS: A total of 98 articles were identified. Of these, 23 articles were selected to construct the guidelines. In these studies, the detection of BCVI increased with the use of a screening protocol versus no screening protocol (odds ratio [OR], 4.74; 95% confidence interval [CI], 1.76-12.78; p = 0.002), as well as among patients with high-risk versus low-risk cervical spine injuries (OR, 12.7; 95% CI, 6.24-25.62; p = 0.003). The use of ATT versus no ATT resulted in a decreased risk of stroke (OR, 0.20; 95% CI, 0.06-0.65; p < 0.0001) and mortality (OR, 0.17; 95% CI, 0.08-0.34; p < 0.0001). There was no significant difference in the risk of stroke among patients with Grade II or III injuries who underwent stenting as an adjunct to ATT versus ATT alone (OR, 1.63; 95% CI, 0.2-12.14; p = 0.63).
CONCLUSION: We recommend using a screening protocol to detect BCVI in blunt polytrauma patients. Among patients with high-risk cervical spine injuries, we recommend screening computed tomography angiography to detect BCVI. For patients with low-risk risk cervical injuries, we conditionally recommend performing a computed tomography angiography to detect BCVI. We recommend the use of ATT in patients diagnosed with BCVI. Finally, we recommend against the routine use of endovascular stents as an adjunct to ATT in patients with Grade II or III BCVIs.
LEVEL OF EVIDENCE: Guidelines, Level III.
参考来源
- Kim DY, Biffl W, Bokhari F, et al. Evaluation and management of blunt cerebrovascular injury: A practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2020. PMID: 32176167. doi:10.1097/TA.0000000000002668
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。